article thumbnail

cbdMD Therapeutics Releases Research Plan

Cannabis Law Report

(NYSE American: YCBD, YCBDpA), one of the leading, and most highly trusted and recognized CBD companies, announced today that its recently formed division, cbdMD Therapeutics, has initiated talks with one of the leading US cannabinoid research institutes, to identify novel cannabinoids for therapeutic use. About cbdMD, Inc. cbdMD, Inc.

article thumbnail

CBD Oil’s Wide Availablity Challenges Medical Research

Puff Puff Post

A multitude of stores sell CBD (cannabidiol) oil now that hemp is legal. State regulations on CBD oil vary from US state to US state. Generally, states and regulators dissuade retailers from selling non-approved substances as medications, but a variety of people use CBD oil for a various medicinal purposes.

CBD 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

CBD Oil’s Wide Availablity Challenges Medical Research

Puff Puff Post

A multitude of stores sell CBD (cannabidiol) oil now that hemp is legal. State regulations on CBD oil vary from US state to US state. Generally, states and regulators dissuade retailers from selling non-approved substances as medications, but a variety of people use CBD oil for a various medicinal purposes.

CBD 52
article thumbnail

Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Completes Acquisition of Oncology Research and Development Company Sapphire Biotech, Inc.

Cannabis Law Report

OTCQB: AXIM) (“AXIM® Biotech” or “AXIM”) has completed the acquisition of leading oncology research and development company Sapphire Biotech, Inc. (“Sapphire”). Valencia has stewarded Sapphire in the development of its unique patent-pending pipeline. About AXIM® Biotechnologies.

article thumbnail

CBD Science Update

Project CBD

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. But would tolerance develop with repeated dosing, thereby mitigating CBD ’s hypotensive effect?

CBD 218
article thumbnail

Prohibition Publish 2nd Ed Of The Pharmaceutical Cannabis Report

Cannabis Law Report

Research on the endocannabinoid system is one of the most promising avenues for new therapeutics in medicine at the moment, however regulations are constantly shifting beneath the feet of operators and their ability to serve patients depends on their capacity to navigate a changing landscape of governance.

article thumbnail

CBD Science Update

Project CBD

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. But would tolerance develop with repeated dosing, thereby mitigating CBD ’s hypotensive effect?

CBD 177